HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.

AbstractAIM:
Poor topical bioavailability and ocular irritation have impeded the development of the diuretic, ethacrynic acid (ECA) as a clinically useful ocular hypotensive for the treatment of glaucoma. Thus, the development of analogs and prodrugs of analogs with improved ocular penetration, potency, and tolerability is required. The aim of this work is to evaluate the corneal penetration and ocular distribution of SA9000, an ECA analog. Novel SA9000 prodrugs intended to further improve ocular pharmacodynamic effect were also evaluated.
RESULTS:
SA9000 penetrated porcine corneas more effectively than ECA in corneal diffusion studies. In vivo studies in Dutch-belted (DB) rabbits indicated that topical application of a single dose (0.3%) of SA9000 could significantly reduce intraocular pressure (IOP) (approximately 25% vs. fellow untreated eye) but caused significant conjunctival hyperemia. Since this hyperemia was likely the result of its inherent thiol reactivity, SA9000 was formulated with equimolar cysteine, an exogenous thiol donor. The administration of increasing SA9000-cysteine adduct concentrations (0.3%, 0.6%, 0.9%) demonstrated that they cause less ocular irritation than unadducted SA9000 but could still significantly reduce IOP (0.3%: 8.7 +/- 2%; 0.6%: 14.4 +/- 5%; 0.9%: 23.3 +/- 4.4%) versus untreated contralateral control eyes.
CONCLUSIONS:
These data suggest that novel thiol donor adduction can improve the ocular bioavailability and tolerability of SA9000. SA9000-cysteine prodrugs may represent a new option for the topical treatment of glaucoma.
AuthorsJohn J Arnold, Yash Choksi, Xin Chen, Atsushi Shimazaki, John Hatten, Eric J Toone, David L Epstein, Pratap Challa
JournalJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (J Ocul Pharmacol Ther) Vol. 25 Issue 3 Pg. 179-86 (Jun 2009) ISSN: 1557-7732 [Electronic] United States
PMID19456251 (Publication Type: Journal Article)
Chemical References
  • Cinnamates
  • Drug Combinations
  • Ophthalmic Solutions
  • Prodrugs
  • SA9000
  • Cysteine
  • Ethacrynic Acid
Topics
  • Administration, Topical
  • Animals
  • Biological Availability
  • Chromatography, High Pressure Liquid
  • Cinnamates (administration & dosage, pharmacokinetics, pharmacology)
  • Conjunctiva (blood supply, drug effects)
  • Conjunctival Diseases (chemically induced)
  • Cornea (metabolism)
  • Cysteine (administration & dosage, pharmacokinetics, pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Ethacrynic Acid (administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology)
  • Hyperemia (chemically induced)
  • In Vitro Techniques
  • Intraocular Pressure (drug effects)
  • Male
  • Ophthalmic Solutions
  • Permeability
  • Prodrugs (administration & dosage, pharmacokinetics, pharmacology)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: